×
Prescription Required

DYNAPAR AQ INJ


Rs 180 10 % Off


Package size

  • Rs 180
  • 5 Soft gelatin Capsules

    Estimate Delivery by: Tomorrow

    Delivering to 201301, Noida


    Easy 7 days return available

    Rs 180 10 % Off

    DYNAPAR AQ INJ

    Dynapar AQ 75mg Injection is a powerful NSAID used to manage acute pain and inflammation in conditions such as arthritis, migraines, and post-operative pain. It contains Diclofenac Sodium, which works by inhibiting the synthesis of prostaglandins, thereby reducing pain and swelling. This medication is administered intramuscularly by healthcare professionals, ensuring precise delivery and effectiveness. Common side effects include nausea, pain at the injection site, and indigestion, with more serious risks involving liver or kidney complications. It is essential for patients with pre-existing conditions to use this medication under medical supervision to avoid adverse effects. Regular monitoring and adherence to the prescribed dosage are crucial for optimal results and safety.

    Product Highlights and Usage:

    Indication: Used for the management of acute pain and inflammation in conditions such as arthritis, migraine, and post-operative pain. Active Ingredient: Contains Diclofenac Sodium, a non-steroidal anti-inflammatory drug (NSAID). Mechanism of Action: Works by reducing substances in the body that cause pain and inflammation. Usage: Administered by a healthcare professional through intramuscular injection. Side Effects: Common side effects include nausea, pain at the injection site, and indigestion; serious effects may include liver or kidney issues.

    4.2
    Date

    Super Admin

    Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s

    medicare-logo-white

    APMEDCARE: Your digital partner in navigating secure, accessible healthcare services.

    Recent Posts

    Our services

    Copyright @ AXOLAB PHARMACEUTICALS PRIVATE LIMITED, 2025. All rights reserved.